236P Survival Outcomes of Patients (pts) with Metastatic Lobular Breast Cancer (mlbc) Receiving Cyclin-Dependent Kinase 4/6 Inhibitors (cdk4/6i) and Endocrine Therapy (ET): A Retrospective Analysis
ESMO Open(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined